p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells. [electronic resource]
Producer: 20130121Description: 19-24 p. digitalISSN:- 1873-569X
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- pharmacology
- Cell Cycle Proteins -- genetics
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Child
- Cisplatin -- pharmacology
- Cyclin-Dependent Kinase Inhibitor p21 -- metabolism
- Dacarbazine -- pharmacology
- Dose-Response Relationship, Drug
- Female
- Gene Expression Regulation, Enzymologic
- Gene Expression Regulation, Neoplastic
- Humans
- Immunohistochemistry
- Male
- Melanoma -- enzymology
- Middle Aged
- Neoplasm Invasiveness
- Neoplasm Staging
- Nimustine -- pharmacology
- Prognosis
- RNA Interference
- Ribonucleotide Reductases -- genetics
- Skin Neoplasms -- enzymology
- Transfection
- Vincristine -- pharmacology
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.